Camurus US
Camurus is a biopharmaceutical company committed to improving the lives of people with severe and chronic diseases.
LinkedIn
LinkedIn
Facebook
Facebook
Instagram
Instagram
FDA accepts NDA for Oclaiz™ (octreotide) for the treatment of acromegaly
FDA accepts NDA for Oclaiz™ (octreotide) for the treatment of acromegaly
SIGN UP - Stay informed with Camurus news
SIGN UP - Stay informed with Camurus news
Camurus – US website
Camurus – US website
US homepage for Camurus, a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases.
CEO Fredrik Tiberg talks with Pituitary World News
CEO Fredrik Tiberg talks with Pituitary World News
I recently had the pleasure of meeting Camurus CEO Fredrik Tiberg. We initially connected on a Zoom call and later met at the European Endocrine Conference held in Copenhagen, Denmark in May. We agreed to meet in person, learn more about the company and record a podcast.
Dr. Markus Johnsson discusses FluidCrystal® technology with Pituitary World News
Dr. Markus Johnsson discusses FluidCrystal® technology with Pituitary World News
In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.
View on mobile
